Focused On-demand Library for Ferritin heavy chain

Focused On-demand Libraries - Reaxense Collaboration

Explore the Potential with AI-Driven Innovation

The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.

We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.

The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.

We employ our advanced, specialised process to create targeted libraries for enzymes.

Fig. 1. The sreening workflow of Receptor.AI

This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.

Several key aspects differentiate our library:

Receptor.AI compiles an all-encompassing dataset on the target protein, including historical experiments, literature data, known ligands, and structural insights, maximising the chances of prioritising the most pertinent compounds.
The platform employs state-of-the-art molecular simulations to identify potential binding sites, ensuring the focused library is primed for discovering allosteric inhibitors and binders of concealed pockets.
Over 50 customisable AI models, thoroughly evaluated in various drug discovery endeavours and research projects, make Receptor.AI both efficient and accurate. This technology is integral to the development of our focused libraries.
In addition to generating focused libraries, Receptor.AI offers a full range of services and solutions for every step of preclinical drug discovery, with a pricing model based on success, thereby reducing risk and promoting joint project success.

partner

Reaxense

upacc

P02794

UPID:

FRIH_HUMAN

Alternative names:

Cell proliferation-inducing gene 15 protein

Alternative UPACC:

P02794; B3KNR5; Q3KRA8; Q3SWW1

Background:

Ferritin heavy chain, also known as Cell proliferation-inducing gene 15 protein, plays a crucial role in iron storage and homeostasis. It stores iron in a soluble, non-toxic form, has ferroxidase activity, and is vital for delivering iron to cells. This protein's ability to mediate iron uptake is especially important in the developing kidney.

Therapeutic significance:

Hemochromatosis 5, a disorder of iron metabolism leading to iron overload and organ failure, is linked to mutations affecting Ferritin heavy chain. Understanding the role of Ferritin heavy chain could open doors to potential therapeutic strategies for managing iron-related disorders.